UK markets closed

Syndax Pharmaceuticals, Inc. (1T3.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
19.90-0.50 (-2.45%)
At close: 08:05AM CEST
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts5566
Avg. Estimate-0.63-0.66-2.3-2.39
Low estimate-0.65-0.69-2.47-2.7
High estimate-0.58-0.62-2.18-2.11
Year ago EPS-0.46-0.44-1.87-2.3
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts4456
Avg. Estimate220k220k1.41M1.42M
Low estimateN/AN/A760kN/A
High estimate500k500k1.76M4M
Year ago sales379k380k1.52M1.41M
Sales growth (year/est)-42.00%-42.10%-7.10%0.70%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-0.44-0.49-0.65-0.71
Actual EPS-0.46-0.44-0.54-0.44
Difference-0.020.050.110.27
Surprise %-4.50%10.20%16.90%38.00%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.63-0.66-2.3-2.39
7 days ago-0.63-0.66-2.3-2.39
30 days ago-0.63-0.66-2.3-2.39
60 days ago-0.53-0.52-2.33-2.19
90 days ago-0.53-0.52-2.33-2.19
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimates1T3.FIndustrySector(s)S&P 500
Current qtr.-37.00%N/AN/AN/A
Next qtr.-50.00%N/AN/AN/A
Current year-23.00%N/AN/AN/A
Next year-3.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A